The University of Dundee and Bio-Techne, a global life sciences company providing innovative tools and bioactive reagents, will partner to commercialise technology developed at Dundee that enhances the understanding of undruggable diseases. Bio-Techne has signed an exclusive licencing agreement to…
Early career researchers in the School have received support from the Scottish Universities Life Sciences Alliance (SULSA) to establish new life sciences networks by providing funds towards the running of a network event. Valentina Spiteri, Charlotte Crowe, and Mark Nakasone,…
Professor Alessio Ciulli has been awarded a European Federation for Medicinal Chemistry and Chemical Biology Awards 2022. He has been named the winner of the 2022 Prous Institute – Overton and Meyer Award for New Technologies in Drug Discovery. This…
University of Dundee spinout Amphista Therapeutics will work with global biopharmaceutical companies as part of strategic collaborations potentially worth more than $2 billion. As part of separate partnerships, Amphista will collaborate with Merck Healthcare and Bristol Myers Squibb to leverage…
Dr Xingui Liu has been awarded a Marie Skłodowska-Curie Fellowship to undertake research in the lab of Professor Alessio Ciulli in the newly established Centre for Targeted Protein Degradation (CeTPD). Dr Xingui Liu has been awarded a Marie Skłodowska-Curie Fellowship…
Targeted protein degradation (TPD) is an innovative field that is revolutionising drug development, with various modalities being explored by researchers to tackle undruggable targets and treat a wide range of diseases, including cancer, neurological disorders, and skin diseases. In this…
Tom & Conner’s review on Targeting Epigenetic Modulators Using PROTAC Degraders is now published in BMCL Great review article by Tom and Conner Read the full article. Authors: Thomas Webb, Conner Craigon, Alessio Ciulli* Title: Targeting Epigenetic Modulators Using PROTAC Degraders: Current Status…
Angus & Alessio’s review on E3 Ligase Substrate Specificity for Targeted Protein Degradation Authors: Angus D. Cowan, Alessio Ciulli* Title: Driving E3 Ligase Substrate Specificity for Targeted Protein Degradation: Lessons from Nature and the Laboratory Abstract Methods to direct the…
William Farnaby has been appointed as Principal Investigator within the newly formed Centre for Targeted Protein Degradation (CeTPD). Will’s research will innovate chemical approaches to discover and develop molecules that can probe new ways of addressing disease. There will be…
Xingui & Alessio’s News & Views article titled “DUB be good to me” is now published in Nat Chem Biol. Read the News & Views article on Nature Chemical Biology website. The title was inspired from Beats International’s song back in 1990…